Droxia Capsule
Product Images NDC 61269-404

7 FDA label images from H2-pharma Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Droxia (NDC 61269-404). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H2-pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hydroxyurea Chemical Structure (Droxia Struct)

Hydroxyurea Chemical Structure (Droxia Struct)
Chemical structure of hydroxyurea showing its molecular arrangement with atoms including oxygen, nitrogen, carbon, and hydrogen, consistent with the active ingredient in DROXIA capsules.*
FDA Label Image

Principal Display Panel (300 mg Capsule Bottle Label)

Principal Display Panel (300 mg Capsule Bottle Label)
Label for DROXIA (hydroxyurea) capsules, 300 mg strength, with a package count of 60 capsules. The label includes cautionary information indicating it is a cytotoxic agent and instructs to dispense the accompanying medication guide. The product is labeled for prescription use only and distributed by CHEPLAPHARM Arzneimittel GmbH and others. The label also specifies storage instructions and handling precautions.*
FDA Label Image

Principal Display Panel (300 mg Capsule Bottle Carton)

Principal Display Panel (300 mg Capsule Bottle Carton)
Packaging label for DROXIA 300 mg capsules containing hydroxyurea, an oral human prescription drug. The label indicates a package size of 60 capsules. It includes cautionary information about handling as a cytotoxic agent and storage instructions. Distributed by H2-Pharma LLC and licensed by CHEPLAPHARM Arzneimittel GmbH. The label features barcodes and dosage warnings.*
FDA Label Image

Principal Display Panel (200 mg Capsule Bottle Label)

Principal Display Panel (200 mg Capsule Bottle Label)
Label for DROXIA (hydroxyurea) capsules, 200 mg strength, containing 60 capsules. The oral capsule dosage form is indicated as Rx only. The label includes warnings about cytotoxicity and handling instructions, distributed by H2-Pharma LLC, Montgomery, AL, and manufactured in Italy by CHEPLAPHARM Arzneimittel GmbH, Germany.*
FDA Label Image

Principal Display Panel (200 mg Capsule Bottle Carton)

Principal Display Panel (200 mg Capsule Bottle Carton)
Packaging label for DROXIA (hydroxyurea) capsules, 200 mg strength. The label includes the proprietary name DROXIA, generic name hydroxyurea, dosage form as capsules, and a caution that it is a cytotoxic agent. The label states a package size of 60 capsules, with storage instructions and handling precautions. Distributed by H2-Pharma, LLC, made in Italy, and licensed by CHEPLAPHARM Arzneimittel GmbH.*
FDA Label Image

Principal Display Panel (400 mg Capsule Bottle Label)

Principal Display Panel (400 mg Capsule Bottle Label)
Label for DROXIA (hydroxyurea) capsules, 400 mg strength, containing 60 capsules. The label includes warnings about cytotoxicity and handling precautions. It lists the distributor as H2-Pharma LLC in Alabama, USA, and the manufacturer as CHEPLAPHARM Arzneimittel GmbH in Germany. The label specifies oral route with Rx only designation and storage instructions.*
FDA Label Image

Principal Display Panel (400 mg Capsule Bottle Carton)

Principal Display Panel (400 mg Capsule Bottle Carton)
Packaging label for DROXIA (hydroxyurea) capsules, 400 mg strength. The label indicates 60 capsules per container and cautions that DROXIA is a cytotoxic agent. It includes handling instructions and storage conditions. The labeler is H2-Pharma LLC, with manufacturing by CHEPLAPHARM, made in Italy. The product is for oral use and prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.